» Articles » PMID: 31795222

Cyclodextrins: Emerging Medicines of the New Millennium

Overview
Journal Biomolecules
Publisher MDPI
Date 2019 Dec 5
PMID 31795222
Citations 65
Authors
Affiliations
Soon will be listed here.
Abstract

Cyclodextrins, since their discovery in the late 19th century, were mainly regarded as excipients. Nevertheless, developments in cyclodextrin research have shown that some of these hosts can capture and include biomolecules, highlighting fatty acids and cholesterol, which implies that they are not inert and that their action may be used in specific medicinal purposes. The present review, centered on literature reports from the year 2000 until the present day, presents a comprehensive description of the known biological activities of cyclodextrins and their implications for medicinal applications. The paper is divided into two main sections, one devoted to the properties and applications of cyclodextrins as active pharmaceutical ingredients in a variety of pathologies, from infectious ailments to cardiovascular dysfunctions and metabolic diseases. The second section is dedicated to the use of cyclodextrins in a range of biomedical technologies.

Citing Articles

Actions and Interactions of Mirror-Image Cyclodextrins.

Armstrong D, Aslani S, Nafie J, Wu Y, Stoddart J JACS Au. 2025; 5(2):693-701.

PMID: 40017754 PMC: 11863152. DOI: 10.1021/jacsau.4c00962.


Characterization of Sugammadex-Related Isomeric Cyclodextrin Impurities Using Cyclic Ion Mobility High-Resolution Mass Spectrometry.

Szakaly P, Papp D, Steckel A, Varga E, Schlosser G J Am Soc Mass Spectrom. 2025; 36(2):258-264.

PMID: 39855639 PMC: 11808773. DOI: 10.1021/jasms.4c00243.


Inactivation of Zika Virus with Hydroxypropyl-Beta-Cyclodextrin.

Hewitt C, Wixon N, Gallegos A, Zhou Y, Huber V, Killian M Vaccines (Basel). 2025; 13(1.

PMID: 39852858 PMC: 11769224. DOI: 10.3390/vaccines13010079.


Host-Guest Complexation of Olmesartan Medoxomil by Heptakis(2,6-di-O-methyl)-β-cyclodextrin: Compatibility Study with Excipients.

Man D, Nitu E, Temereanca C, Sbarcea L, Ledeti A, Ivan D Pharmaceutics. 2025; 16(12.

PMID: 39771536 PMC: 11677897. DOI: 10.3390/pharmaceutics16121557.


Anti-inflammatory effects of cyclodextrin nanoparticles enable macrophage repolarization and reduce inflammation.

Brettner F, Gier S, Haessler A, Schreiner J, Vogel-Kindgen S, Windbergs M Discov Nano. 2024; 19(1):211.

PMID: 39707045 PMC: 11662127. DOI: 10.1186/s11671-024-04175-6.


References
1.
Crandall I, Szarek W, Vlahakis J, Xu Y, Vohra R, Sui J . Sulfated cyclodextrins inhibit the entry of Plasmodium into red blood cells. Implications for malarial therapy. Biochem Pharmacol. 2006; 73(5):632-42. DOI: 10.1016/j.bcp.2006.10.030. View

2.
Szente L, Singhal A, Domokos A, Song B . Cyclodextrins: Assessing the Impact of Cavity Size, Occupancy, and Substitutions on Cytotoxicity and Cholesterol Homeostasis. Molecules. 2018; 23(5). PMC: 6100472. DOI: 10.3390/molecules23051228. View

3.
Farmer C, Thurm A, Farhat N, Bianconi S, Keener L, Porter F . Long-Term Neuropsychological Outcomes from an Open-Label Phase I/IIa Trial of 2-Hydroxypropyl-β-Cyclodextrins (VTS-270) in Niemann-Pick Disease, Type C1. CNS Drugs. 2019; 33(7):677-683. PMC: 7448545. DOI: 10.1007/s40263-019-00642-2. View

4.
Pucadyil T, Tewary P, Madhubala R, Chattopadhyay A . Cholesterol is required for Leishmania donovani infection: implications in leishmaniasis. Mol Biochem Parasitol. 2003; 133(2):145-52. DOI: 10.1016/j.molbiopara.2003.10.002. View

5.
Lee C, Lin H, Liao C, Lin Y . Cholesterol effectively blocks entry of flavivirus. J Virol. 2008; 82(13):6470-80. PMC: 2447114. DOI: 10.1128/JVI.00117-08. View